Literature DB >> 24511827

[Hantaviruses in Germany: threat for zoo, pet, companion and farm animals?].

Rainer G Ulrich1, Christian Imholt2, Detlev H Krüger3, Ellen Krautkrämer2, Thomas Scheibe4, Sandra S Essbauer5, Martin Pfeffer6.   

Abstract

Hantaviruses are so-called "emerging" and "re-emerging" viruses because of the new and sudden nature of their appearance. Human infections can lead to two distinct disease patterns, the Haemorrhagic Fever with Renal Syndrome and the Hantavirus Cardiopulmonary Syndrome. All known human pathogenic hantaviruses are transmitted through rodent hosts. There are three rodent-associated hantaviruses in Germany. The bank vole-associated Puumala virus (PUUV) is responsible for most of the human hantavirus infections. The Dobrava-Belgrade virus (DOBV) associated with the striped field mouse is causing hantavirus disease in the North and Northeast of Germany. The human pathogenicity of Tula virus (TULV) is still controversially discussed--the virus has been mainly associated with the common vole as the reservoir, but was molecularly detected also in the field and the water vole. More recently, two shrew-borne hantaviruses were described in Germany, i. e. Seewis virus in the common shrew and Asikkala virus in the pygmy shrew. Systematic studies about hantavirus infections of zoo, pet, companion and farm animals are still lacking. Hence, the aim of this review article is to summarise the current knowledge on this topic and raise the attention of veterinarians to potentially overlooked clinical disease patterns.

Entities:  

Mesh:

Year:  2013        PMID: 24511827

Source DB:  PubMed          Journal:  Berl Munch Tierarztl Wochenschr        ISSN: 0005-9366            Impact factor:   0.328


  1 in total

1.  Detection of Puumala hantavirus antigen in human intestine during acute hantavirus infection.

Authors:  Joerg Latus; Klara Tenner-Racz; Paul Racz; Daniel Kitterer; Daniel Cadar; German Ott; M Dominik Alscher; Jonas Schmidt-Chanasit; Niko Braun
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.